KELLY COYLE: Open Payments
NPI 1851993182 · BOZEMAN, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 33 payments from 8 companies in 2025. Trend: 2023 $848 · 2024 $682 · 2025 $548
Food & beverage: $538Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $252 |
| Novartis Pharmaceuticals Corporation | 5 | $84 |
| LEO Pharma Inc. | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| GENZYME CORPORATION | 1 | $27 |
| Lilly USA, LLC | 1 | $19 |
| MERZ NORTH AMERICA, INC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: SKYRIZI, COSENTYX, ADBRY, DUPIXENT, RINVOQ, TALTZ, LIBTAYO, SPEVIGO.
Industry payments across MT — which companies pay providers there.
